在初级和匹配的转移性宫癌病变中,组织因子,TROP2和NECTIN4的同时表达
Marit L Ulvang1, Oda Fløtre Kvile1, Hege F Berg1
1Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Translational oncology
|June 27, 2025
概括
抗体-药物结合标,组织因子和TROP2,在宫癌 (CC) 中高度表达. 复发性CC中NECTIN4表达增加,支持这些有前途的治疗方法的临床试验.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 药物开发 药物开发
背景情况:
- 宫癌 (CC) 的预后会在晚期或复发性疾病中恶化,在这种情况下,治疗选择有限.
- 抗体-药物合物 (ADCs) 在各种癌症中表现出潜力,但在CC中未得到充分研究.
研究的目的:
- 评估ADC目标在初级和转移性CC中的表达.
- 为了确定可能对宫癌的ADC治疗有反应的患者.
主要方法:
- 在522个初级和194个转移性CC病变中使用免疫组织化学研究组织因子,TROP2和NECTIN4的膜表达.
- 与临床病理特征和患者随访数据相关的表达水平.
主要成果:
- 组织因子,TROP2和NECTIN4显示癌细胞特异性表达.
- 在68%的原发性瘤中发现TROP2的高表达 (≥2+),在48%的瘤中发现组织因子.
- 在原发性瘤中,nectin4的表达从12%增加到复发性病变中的38%.
结论:
- 组织因子和TROP2在初级和转移性CC中都高度表达,表明ADC治疗的潜力.
- 在复发性CC中,nectin4的表达显著增加,这表明它在晚期疾病中有用.
- 这些发现支持针对针对组织因子,TROP2和NECTIN4的ADC在宫癌治疗中的临床试验.
关键词:
ADC的目标目标是ADC的目标.宫癌是发生在宫癌的原因之一.免疫组织化学 免疫组织化学转移性病变是一种转移性病变.尼克丁 (NECTIN) 是一种4复发性疾病是复发性疾病.这就是TROP2的原因.组织因子 组织因子更多相关视频
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
8.2K
08:00Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
7.6K
相关概念视频
02:30Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K